Key Metrics
3 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Indexed in the following public directories
-
Web of Science -
DOAJ
Journal Specifications
| Overview | |
| Publisher | DOVE MEDICAL PRESS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2390 |
| Publication Time | 16 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2011 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 16 |
| Article Processing Charges | USD 2390 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
Planning to publish in PSORIASIS-TARGETS AND THERAPY ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Commercial Diagnostics and Emerging Precision Medicine Technologies in Psoriasis and Atopic Dermatitis.
- 1 Aug 24
- Psoriasis (Auckland, N.Z.)
-
Full paper
Effectiveness and Drug Survival of Ixekizumab and Secukinumab in Patients with Moderate to Severe Plaque Psoriasis: Real-World Data from Bucharest, Romania.
- 1 Jun 24
- Psoriasis (Auckland, N.Z.)
-
Full paper
Burden of Herpes Zoster Among Patients with Psoriatic Arthritis in the United States
- 1 Jun 24
- Psoriasis: Targets and Therapy
-
Full paper
The Perspective of Cannabidiol in Psoriasis Therapy.
- 1 Jun 24
- Psoriasis (Auckland, N.Z.)
-
Full paper
Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest Registries.
- 1 May 24
- Psoriasis: Targets and Therapy
-
Full paper
Therapeutic Potential of Spesolimab-Sbzo in the Management of Generalized Pustular Psoriasis Flares in Adults: Evidence to Date.
- 1 Mar 24
- Psoriasis (Auckland, N.Z.)
Scite analysis
Powered by scite_
144 articles received 1.9k citations see all
- 53 Supporting
- 1,755 Mentioning
- 5 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 0 Corrections
- 2 Errata
- 0 Expression of Concern
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
43%
4 to 6 months
57%
7 to 9 months
0%
Above 9 months
0%
Did you find this useful?
Thank you for your feedback.
FAQs
How long has PSORIASIS-TARGETS AND THERAPY been actively publishing?
PSORIASIS-TARGETS AND THERAPY has been in operation since 2011 till date.
What is the publishing frequency of PSORIASIS-TARGETS AND THERAPY ?
PSORIASIS-TARGETS AND THERAPY published with a Continuous publication frequency.
How many articles did PSORIASIS-TARGETS AND THERAPY publish last years ?
In 2023, PSORIASIS-TARGETS AND THERAPY published 7 articles.
What is the eISSN & pISSN for PSORIASIS-TARGETS AND THERAPY ?
For PSORIASIS-TARGETS AND THERAPY,eISSN is 2230-326X and pISSN is2230-326X.
Who is the publisher of PSORIASIS-TARGETS AND THERAPY ?
DOVE MEDICAL PRESS LTD is the publisher of PSORIASIS-TARGETS AND THERAPY.